 | Up a level |
Journal Article
Al-Batran, S-E., Hofheinz, R. D., Schmalenberg, H., Strumberg, D., Goekkurt, E., Angermeier, S., Zander, T., Potenberg, J., Kopp, H-G., Pink, D., Siegler, G. M., Schenk, M., De Vita, F., Maiello, E., Gaiser, T., Sookthai, D., Bankstahl, U. S., Pauligk, C., Goetze, T. O. and Homann, N. (2020). Perioperative FLOT plus ramucirumab versus FLOT alone for resectable esophagogastric adenocarcinoma- Updated results and subgroup analyses of the randomized phase II/III trial RAMSES/FLOT7 of the German AIO and Italian GOIM. Ann. Oncol., 31. S. S901 - 1. AMSTERDAM: ELSEVIER. ISSN 1569-8041
Gathof, B., Homann, N., Mrotzek, M., Petrescu-Jipa, V. M., Stoermer, M., Steven, P., Cursiefen, C. and Radojska, S. (2017). Autologous serum eye drops: five years' experience of manufacturing. Transfus. Med. Hemother., 44. S. 85 - 87. BASEL: KARGER. ISSN 1660-3818
Mrotzek, M., Homann, N., Petrescu-Jipa, V. M., Radojska, S., Steven, P., Cursiefen, C., Stoermer, M. and Gathof, B. (2017). Serum eye drops: first experience of manufacturing and treatment in allogeneic setting. Transfus. Med. Hemother., 44. S. 87 - 88. BASEL: KARGER. ISSN 1660-3818